Instrucciones de búsqueda:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Navegar por los elementos (92 total)
-
Autor: Koch, Till, Christine Dahlke, Anahita Fathi, Alexandra Kupke, Verena Krähling, Nisreen M. A. Okba, Sandro Halwe, Cornelius Rohde, Markus Eickmann, Asisa Volz, Thomas Hesterkamp, Alen Jambrecina, Saskia Borregaard, My L. Ly, Madeleine E. Zinser,…
Tema: Laboratory
Tipo de elemento: Publicación
Fecha de actualización: 2020-04-20
Descripción: The Middle East respiratory syndrome coronavirus (MERS-CoV) causes a respiratory disease with a case fatality rate of up to 35%. -
Autor: Castanha, Priscila M. S., and Ernesto T. A. Marques.
Tema: Laboratory
Tipo de elemento: Publicación
Fecha de actualización: 2020-05-06
Descripción: The North and South American continents experienced a major epidemic of Zika virus in 2015–16, which infected up to 70% of the population in some areas. -
Autor: NIH
Tema: Infection Control
Tipo de elemento: Hipervínculo
Fecha de actualización: 2020-05-04
Descripción: This is a phase I, open-label, dose ranging clinical trial in males and non-pregnant females, starting at 18 years of age, inclusive, who are in good health and meet all eligibility criteria. This clinical trial is designed to assess the safety,… -
Autor: the mRNA-1273 Study Group
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2020-07-14
Descripción: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in late 2019 and spread globally, prompting an international effort to accelerate development of a vaccine. The candidate vaccine mRNA-1273 encodes the stabilized prefusion… -
Autor: Oxford COVID Vaccine Trial Group
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2020-07-20
Descripción: The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) might be curtailed by vaccination. We assessed the safety, reactogenicity, and immunogenicity of a viral vectored coronavirus vaccine that expresses the spike protein of… -
Autor: Zhu, Feng-Cai, Xu-Hua Guan, Yu-Hua Li, Jian-Ying Huang, Tao Jiang, Li-Hua Hou, Jing-Xin Li, Bei-Fang Yang, Ling Wang, Wen-Juan Wang, Shi-Po Wu, Zhao Wang, Xiao-Hong Wu, Jun-Jie Xu, Zhe Zhang, Si-Yue Jia, Bu-Sen Wang, Yi Hu, Jing-Jing Liu, Jun Zhang,…
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2020-07-20
Descripción: This is the first randomised controlled trial for assessment of the immunogenicity and safety of a candidate non-replicating adenovirus type-5 (Ad5)-vectored COVID-19 vaccine, aiming to determine an appropriate dose of the candidate vaccine for an… -
Autor: Ibarrondo, F. Javier, Jennifer A. Fulcher, David Goodman-Meza, Julie Elliott, Christian Hofmann, Mary A. Hausner, Kathie G. Ferbas, Nicole H. Tobin, Grace M. Aldrovandi, and Otto O. Yang.
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2020-07-21
Descripción: A recent article suggested the rapid decay of anti–SARS-CoV-2 IgG in early infection, but the rate was not described in detail. We evaluated persons who had recovered from Covid-19 and referred themselves to our institution for observational… -
Autor: Corbett, Kizzmekia S., Barbara Flynn, Kathryn E. Foulds, Joseph R. Francica, Seyhan Boyoglu-Barnum, Anne P. Werner, Britta Flach, Sarah O’Connell, Kevin W. Bock, Mahnaz Minai, Bianca M. Nagata, Hanne Andersen, David R. Martinez, Amy T. Noe, Naomi…
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2020-07-28
Descripción: Vaccines to prevent coronavirus disease 2019 (Covid-19) are urgently needed. The effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines on viral replication in both upper and lower airways is important to evaluate in nonhuman… -
Autor: Davis, Carl W., Katherine J. L. Jackson, Megan M. McCausland, Jaime Darce, Cathy Chang, Susanne L. Linderman, Chakravarthy Chennareddy, Rebecca Gerkin, Shantoria J. Brown, Jens Wrammert, Aneesh K. Mehta, Wan Cheung Cheung, Scott D. Boyd, Edmund K.…
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2020-08-13
Descripción: A universal vaccine against influenza would ideally generate protective immune responses that are not only broadly reactive against multiple influenza strains, but also long-lasting. Because long-term serum antibody levels are maintained by bone… -
Autor: Logunov, Denis Y., Inna V. Dolzhikova, Olga V. Zubkova, Amir I. Tukhvatullin, Dmitry V. Shcheblyakov, Alina S. Dzharullaeva, Daria M. Grousova, Alina S. Erokhova, Anna V. Kovyrshina, Andrei G. Botikov, Fatima M. Izhaeva, Olga Popova, Tatiana A.…
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2020-09-21
Descripción: We developed a heterologous COVID-19 vaccine consisting of two components, a recombinant adenovirus type 26 (rAd26) vector and a recombinant adenovirus type 5 (rAd5) vector, both carrying the gene for severe acute respiratory syndrome coronavirus 2…